Based on these findings, we hypothesized that DYRK1A inhibitor-mediated ERK hyperphosphorylation may result in negative selection and cell cycle arrest in KMT2A-R ALL cells. The gene discussed is DYRK1A; the disease is acute lymphoblastic leukemia.